Advanced Pancreatic Carcinoma (DBCOND0054374)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06630325	A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced, Recurrent Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer	Abemaciclib Carboplatin Doxorubicin Exemestane Fulvestrant Gefitinib Gemcitabine Letrozole Olaparib Osimertinib Paclitaxel Pemetrexed Tamoxifen Temozolomide Tetracycline	treatment	2	not_yet_recruiting
NCT04550494	Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations	Talazoparib	treatment	2	recruiting
NCT05969860	At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced Cancer	No drug interventions	health_services_research	2	recruiting
NCT05053971	Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas	Entinostat	treatment	1 / 2	recruiting
NCT05304936	HCW9218 for Advanced Pancreatic Cancer	No drug interventions	treatment	1 / 2	active_not_recruiting
NCT03033225	Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study	Verteporfin	treatment	2	completed
NCT05143151	CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer	No drug interventions	treatment	1 / 2	unknown_status
NCT05620732	Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T	No drug interventions	treatment	Not Available	recruiting
NCT05733000	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors	Devimistat Fluorouracil Gemcitabine Hydroxychloroquine Lipoic acid	treatment	2	recruiting
NCT05257122	A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer	Fruquintinib	treatment	2	unknown_status
NCT05238831	SMMART Adaptive Clinical Treatment (ACT) Trial	Albumin human Alectinib Alpelisib Anastrozole Atezolizumab Bevacizumab Capecitabine Carboplatin Cobimetinib Entrectinib Eribulin Fulvestrant Hyaluronidase (human recombinant) Irinotecan Letrozole Niraparib Olaparib Paclitaxel Palbociclib Pertuzumab Trastuzumab Trastuzumab emtansine Vemurafenib Vinorelbine Vismodegib	treatment	0	withdrawn
NCT01454180	Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets	Capecitabine Erlotinib Fluorouracil Gemcitabine Irinotecan Leucovorin	treatment	2	completed
NCT05759923	First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours	No drug interventions	treatment	1	recruiting
NCT05526443	Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)	No drug interventions	Not Available	Not Available	recruiting